Deborah M. Messemer, Director at Allogene Therapeutics, Inc. (ALLO), sold 73,770 shares at $1.42 ($105K) on 2025-06-10, disclosed to the SEC on 2025-06-12.
Scheduled sale ($105k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.42 | 36,885 | $52K | 50.0% |
| 2 | $1.42 | 36,885 | $52K | 50.0% |
| Total | $1.42 avg | 73,770 | $105K | 100% |
| Filing → |
| ALLO | SELL | 2025-02-20 | $32K | — | Filing → |
| TPG | SELL | 2025-01-15 | $210K | — | Filing → |
| ALLO | SELL | 2024-12-10 | $20K | — | Filing → |